17 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Meta+ Bone Cement & M.U.S.T. Fenestrated Pedicle Screw System

FDA 510(k)
FDA Class 2 ·Orthopedic

M.U.S.T. PEDICLE SCREW SYSTEM

FDA Adverse Event
Injury ·MEDACTA INTERNATIONAL SA·Product code PML·February 26, 2026

M.U.S.T. PEDICLE SCREW SYSTEM

FDA Adverse Event
Malfunction ·MEDACTA INTERNATIONAL SA·Product code PML·November 13, 2025

Mui Scientific

FDA UDI
H & A Mui Enterprises Inc·00678467507631·Customized Reusable Esophageal 24 Channel Catheter

Portex

FDA UDI
ICU MEDICAL, INC.·15019517069969·

SKIN LEVEL GASTROSTOMY TUBE KIT (ECSL)

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

AZUL PERSONAL LUBRICANT

FDA 510(k)
FDA Class 2 ·Obstetrics/Gynecology

INTEGRATED APO SET W/CASSETTE3-PRONG

FDA Adverse Event
Injury ·BAXTER HEALTHCARE·Product code FKX·November 21, 2008

MEDISENSE OPTIUM

FDA Adverse Event
Malfunction ·Product code NBW·September 9, 2011

9900

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·July 18, 2013

LIBERTY CYCLER SET, SINGLE CONN./EXT. DL

FDA Adverse Event
Malfunction ·REYNOSE MANUFACTURING·Product code FKX·August 19, 2011

BELLATEK HYBRID BAR 4 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·December 26, 2024

BELLATEK HYBRID BAR 4 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·January 6, 2025

BELLATEK¿ HYBRID BAR 5 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·February 18, 2025

BELLATEK HYBRID BAR 5 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·March 18, 2025

BELLATEK HYBRID BAR 4 IMPLANTS

FDA Adverse Event
Malfunction ·BIOMET 3I·Product code NHA·January 6, 2025

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014